| Literature DB >> 30602462 |
Kristien J Ledeganck1, Els M Gielis1, Daniel Abramowicz1,2, Peter Stenvinkel3, Paul G Shiels4, Amaryllis H Van Craenenbroeck5,2,3.
Abstract
MicroRNAs are epigenetic regulators of gene expression at the posttranscriptional level. They are involved in intercellular communication and crosstalk between different organs. As key regulators of homeostasis, their dysregulation underlies several morbidities including kidney disease. Moreover, their remarkable stability in plasma and urine makes them attractive biomarkers. Beyond biomarker studies, clinical microRNA research in nephrology in recent decades has focused on the discovery of specific microRNA signatures and the identification of novel targets for therapy and/or disease prevention. However, much of this research has produced equivocal results and there is a need for standardization and confirmation in prospective trials. This review aims to provide an overview of general concepts and available clinical evidence in both the pathophysiology and biomarker fields for the role of microRNA in AKI and kidney transplantation.Entities:
Keywords: Acute Kidney Injury; Biomarkers; Body Fluids; Homeostasis; MicroRNAs; Prospective Studies; kidney transplantation
Mesh:
Substances:
Year: 2019 PMID: 30602462 PMCID: PMC6419285 DOI: 10.2215/CJN.08020718
Source DB: PubMed Journal: Clin J Am Soc Nephrol ISSN: 1555-9041 Impact factor: 8.237